Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer
NCT04608409
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Cancer
Interventions
DRUG:
Lapatinib and Paclitaxel
Sponsor
Frederick R. Ueland, M.D.
Collaborators
[object Object]